Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediVera Compounding Pharmacy is a PCAB-accredited compounding pharmacy based in Troy, Michigan, specializing in personalized medication solutions. Founded in 1999 as University Compounding Pharmacy, the company rebranded in 2024 to reflect its national expansion and commitment to innovative healthcare. The pharmacy provides a wide range of custom formulations, including bio-identical hormone replacement therapy (BHRT), weight management treatments like semaglutide and tirzepatide, and specialized medications for dermatology and sexual health. MediVera operates a state-of-the-art 56,000-square-foot facility and is licensed to serve patients and providers in over 45 states. The company is family-owned and emphasizes high-quality standards, holding accreditation in both sterile and non-sterile compounding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediVera Compounding Pharmacy.